Exact Sciences Corporation
EXAS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $3 | $2 | $2 | $2 |
| % Growth | 10.4% | 19.9% | 17.9% | – |
| Cost of Goods Sold | $1 | $1 | $1 | $0 |
| Gross Profit | $2 | $2 | $1 | $1 |
| % Margin | 69.5% | 70.5% | 68.3% | 74% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1 | $1 | $1 | $1 |
| SG&A Expenses | $2 | $2 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $1 | $1 |
| Other Operating Expenses | $1 | -$0 | $0 | $0 |
| Operating Expenses | $3 | $2 | $2 | $2 |
| Operating Income | -$1 | -$0 | -$1 | -$1 |
| % Margin | -38% | -8.6% | -28.5% | -48.4% |
| Other Income/Exp. Net | $0 | $0 | -$0 | $0 |
| Pre-Tax Income | -$1 | -$0 | -$1 | -$1 |
| Tax Expense | -$0 | $0 | -$0 | -$0 |
| Net Income | -$1 | -$0 | -$1 | -$1 |
| % Margin | -37.3% | -8.2% | -29.9% | -33.7% |
| EPS | -5.59 | -1.13 | -3.54 | -3.48 |
| % Growth | -394.7% | 68.1% | -1.7% | – |
| EPS Diluted | -5.59 | -1.13 | -3.54 | -3.48 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1 | $0 | -$0 | -$1 |
| % Margin | -28.6% | 1.2% | -20.2% | -36.7% |